TP53 and neoplasm: This tumor spectrum is wider than what was observed for tp53M214K mutants identified by TILILNG and tp53I166T identified in an ENU forward genetic screen [50,60], indicating that tumor onset and phenotype might depend on the nature of the tp53 mutation.